Literature DB >> 11004134

Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?

K Raza1, J Thambyrajah, J N Townend, A R Exley, C Hortas, A Filer, D M Carruthers, P A Bacon.   

Abstract

BACKGROUND: Chronic inflammatory rheumatic disorders are associated with excess cardiovascular mortality. This may result from arteriosclerosis following inflammatory damage to the vessel wall by vasculitis. Our hypothesis that vasculitis results in arteriosclerosis by causing vascular endothelial dysfunction was tested in patients with primary systemic necrotizing vasculitis (SNV). METHODS AND
RESULTS: Endothelial function was assessed in cross-sectional and longitudinal studies of patients with primary SNV by measuring flow-mediated, endothelium-dependent brachial artery vasodilatation. These patients exhibited marked endothelial dysfunction compared with controls. Remission induction in patients with active primary SNV restored endothelial function.
CONCLUSIONS: Endothelial function is significantly impaired in adults with primary SNV, supporting the hypothesis that premature arteriosclerosis in chronic inflammatory rheumatic disorders results from endothelial dysfunction secondary to vasculitis. Normalization of endothelial function after the treatment of primary SNV suggests that early suppression of disease activity in chronic inflammatory rheumatic disorders may reduce long-term vascular damage. The role of inflammation in atheroma formation is increasingly appreciated; this work raises questions regarding the potential for anti-inflammatory therapy in atherosclerosis itself.

Entities:  

Mesh:

Year:  2000        PMID: 11004134     DOI: 10.1161/01.cir.102.13.1470

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

1.  Temporal heterogeneity of endothelium-dependent and -independent dilatation of brachial artery in patients with coronary artery disease.

Authors:  Attila Pálinkás; Eszter Tóth; Lucia Venneri; Fausto Rigo; Miklós Csanády; Eugenio Picano
Journal:  Int J Cardiovasc Imaging       Date:  2002-10       Impact factor: 2.357

Review 2.  Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

Authors:  Maria C Cid; Marta Segarra; Ana García-Martínez; Jose Hernández-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

3.  Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis.

Authors:  G Chironi; C Pagnoux; A Simon; M Pasquinelli-Balice; M Del-Pino; J Gariepy; L Guillevin
Journal:  Heart       Date:  2006-08-29       Impact factor: 5.994

4.  Endothelial dysfunction in patients with primary Sjögren's syndrome.

Authors:  Timur Pirildar; Canan Tikiz; Sabriye Ozkaya; Serdar Tarhan; Ozan Utük; Hakan Tikiz; Uğur Kemal Tezcan
Journal:  Rheumatol Int       Date:  2005-06-17       Impact factor: 2.631

5.  Arterial stiffness in Behcet's disease: increased regional pulse wave velocity values.

Authors:  H K Chang; S K Kim; S S Lee; M Y Rhee
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

6.  Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitis.

Authors:  K Raza; D M Carruthers; R Stevens; A D Filer; J N Townend; P A Bacon
Journal:  Ann Rheum Dis       Date:  2005-12-16       Impact factor: 19.103

7.  DHEA inhibits vascular remodeling following arterial injury: a possible role in suppression of inflammation and oxidative stress derived from vascular smooth muscle cells.

Authors:  Jiangbin Chen; Lin Xu; Congxin Huang
Journal:  Mol Cell Biochem       Date:  2013-11-28       Impact factor: 3.396

8.  Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Authors:  Katja B Vallbracht-Israng; Andreas Morguet; Peter L Schwimmbeck
Journal:  Can J Cardiol       Date:  2007-11       Impact factor: 5.223

9.  Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients.

Authors:  Alexandre Wagner Silva de Souza; Henrique Ataíde Mariz; Edgard Torres Reis Neto; Anne Elizabeth Diniz Arraes; Neusa Pereira da Silva; Emília Inoue Sato
Journal:  Clin Rheumatol       Date:  2008-12-05       Impact factor: 2.980

10.  Perimyocarditis and myocardial infarction: A rare manifestation of Churg-Strauss syndrome.

Authors:  Christoph Gräni; Thomas Langenegger; Anja Fäh; David Kurz; Rainer Zbinden; David Ramsay
Journal:  Exp Clin Cardiol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.